| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia–like IBMFS ADH5/ALDH2 deficiency
|
Mu, Anfeng
|
|
|
137 |
15 |
p. 2021-2032
|
artikel
|
| 2 |
Anti-CD44 (Kur)lander hits ITP
|
Kapur, Rick
|
|
|
137 |
15 |
p. 1997-1999
|
artikel
|
| 3 |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition
|
Norris, Peter A.A.
|
|
|
137 |
15 |
p. 2114-2124
|
artikel
|
| 4 |
Cancer genes and blood clots
|
Rak, Janusz
|
|
|
137 |
15 |
p. 1996-1997
|
artikel
|
| 5 |
Carpio C, Bouabdallah R, Ysebaert L, et al. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. Blood. 2020;135(13):996-1007.
|
|
|
|
137 |
15 |
p. 2126
|
artikel
|
| 6 |
Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich ataxia fibroblasts
|
Petit, Floriane
|
|
|
137 |
15 |
p. 2090-2102
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
137 |
15 |
p. i
|
artikel
|
| 8 |
ELIPSIS: developing tools to better understand VOC in SCD
|
Shah, Nirmish
|
|
|
137 |
15 |
p. 1987-1988
|
artikel
|
| 9 |
Endogenous formaldehyde destroys blood stem cells
|
Jung, Moonjung
|
|
|
137 |
15 |
p. 1988-1990
|
artikel
|
| 10 |
Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers
|
Pittman, Debra D.
|
|
|
137 |
15 |
p. 2010-2020
|
artikel
|
| 11 |
Familial patterns of hematologic precursors
|
Landgren, Ola
|
|
|
137 |
15 |
p. 1992-1993
|
artikel
|
| 12 |
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
|
Dunbar, Andrew
|
|
|
137 |
15 |
p. 2103-2113
|
artikel
|
| 13 |
How I manage acquired pure red cell aplasia in adults
|
Gurnari, Carmelo
|
|
|
137 |
15 |
p. 2001-2009
|
artikel
|
| 14 |
Increased B4GALT1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in MPNs
|
Di Buduo, Christian A.
|
|
|
137 |
15 |
p. 2085-2089
|
artikel
|
| 15 |
Iron, FRDA, and intermediary metabolism
|
Pantopoulos, Kostas
|
|
|
137 |
15 |
p. 1994-1995
|
artikel
|
| 16 |
“Mast”ering drug discovery with iPSCs
|
Dorrance, Adrienne
|
|
|
137 |
15 |
p. 1993-1994
|
artikel
|
| 17 |
Natural history of MBL in relatives of CLL families
|
|
|
|
137 |
15 |
p. 2127
|
artikel
|
| 18 |
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families
|
Slager, Susan L.
|
|
|
137 |
15 |
p. 2046-2056
|
artikel
|
| 19 |
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis
|
Toledo, Marcelo A.S.
|
|
|
137 |
15 |
p. 2070-2084
|
artikel
|
| 20 |
Polytypic T-cell prolymphocytic leukemia
|
Ames, Erik
|
|
|
137 |
15 |
p. 2125
|
artikel
|
| 21 |
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis
|
Kalinichenko, Artem
|
|
|
137 |
15 |
p. 2033-2045
|
artikel
|
| 22 |
RHOG: Rac1-ing up another HLH gene
|
Nichols, Kim E.
|
|
|
137 |
15 |
p. 1990-1991
|
artikel
|
| 23 |
Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition
|
Bala Tannan, Neeta
|
|
|
137 |
15 |
p. 2057-2069
|
artikel
|
Tijdschrift beschrijving